Chronic myeloid leukemia, version 2.2021, NCCN clinical practice guidelines in oncology
MW Deininger, NP Shah, JK Altman, E Berman… - Journal of the National …, 2020 - jnccn.org
Chronic myeloid leukemia (CML) is defined by the presence of Philadelphia chromosome
(Ph) which results from a reciprocal translocation between chromosomes 9 and 22 [t (9; 22] …
(Ph) which results from a reciprocal translocation between chromosomes 9 and 22 [t (9; 22] …
Chronic myeloid leukemia, version 1.2019, NCCN clinical practice guidelines in oncology
JP Radich, M Deininger, CN Abboud, JK Altman… - Journal of the National …, 2018 - jnccn.org
Chronic myeloid leukemia (CML) is defined by the presence of Philadelphia chromosome
(Ph), resulting from a reciprocal translocation between chromosomes 9 and 22 [t (9; 22] that …
(Ph), resulting from a reciprocal translocation between chromosomes 9 and 22 [t (9; 22] that …
Chronic myeloid leukemia, version 2.2024, nccn clinical practice guidelines in oncology
NP Shah, R Bhatia, JK Altman, M Amaya… - Journal of the National …, 2024 - jnccn.org
Chronic myeloid leukemia (CML) is defined by the presence of Philadelphia chromosome
resulting from a reciprocal translocation between chromosomes 9 and 22 [t9; 22] that gives …
resulting from a reciprocal translocation between chromosomes 9 and 22 [t9; 22] that gives …
[图书][B] Leukaemia diagnosis
BJ Bain - 2017 - books.google.com
From the bestselling author, Barbara J. Bain, the new edition of this practical reference on
the principles of leukaemia diagnosis and classification has been fully updated, and …
the principles of leukaemia diagnosis and classification has been fully updated, and …
Chronic myeloid leukemia: current perspectives
Y Zhang, JD Rowley - Clinics in laboratory medicine, 2011 - labmed.theclinics.com
Chronic myeloid leukemia (CML) is a rare type of leukemia (1–2 per 100,000 people) but is
the most common chronic myeloproliferative neoplasm with the proliferation of multiple …
the most common chronic myeloproliferative neoplasm with the proliferation of multiple …
Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete …
N Testoni, G Marzocchi, S Luatti… - Blood, The Journal …, 2009 - ashpublications.org
In chronic myeloid leukemia, different methods are available to monitor the response to
therapy: chromosome banding analysis (CBA), interphase fluorescence in situ hybridization …
therapy: chromosome banding analysis (CBA), interphase fluorescence in situ hybridization …
Chronic myelogenous leukemia
S O'Brien, CN Abboud, M Akhtari, J Altman… - Journal of the National …, 2012 - jnccn.org
Chronic Myelogenous Leukemia in: Journal of the National Comprehensive Cancer Network
Volume 10 Issue 1 (2012) Jump to Content User Account Sign In to save searches and …
Volume 10 Issue 1 (2012) Jump to Content User Account Sign In to save searches and …
Peripheral blood monitoring of chronic myeloid leukemia during treatment with imatinib, second‐line agents, and beyond
L Lima, L Bernal‐Mizrachi, D Saxe, KP Mann… - Cancer, 2011 - Wiley Online Library
BACKGROUND: The current study was conducted to compare simultaneously obtained
bone marrow (BM) cytogenetics (CTG), peripheral blood (PB) and BM fluorescence in situ …
bone marrow (BM) cytogenetics (CTG), peripheral blood (PB) and BM fluorescence in situ …
[PDF][PDF] Comparison of the efficacy of nilotinib and imatinib in the treatment of chronic myeloid leukemia
BS Zhang, YP Chen, JL Lv, Y Yang - J. Coll. Physicians Surg. Pak, 2019 - jcpsp.pk
Objective: To compare the efficacy of nilotinib and imatinib in the treatment of chronic
myeloid leukemia (CML). Study Design: Analytical study. Place and Duration of Study …
myeloid leukemia (CML). Study Design: Analytical study. Place and Duration of Study …
Chronic myeloid leukemia: cytogenetic methods and applications for diagnosis and treatment
CM Morris - Cancer Cytogenetics: Methods and Protocols, 2011 - Springer
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disease caused by
recombination between the BCR gene on chromosome 22 and the ABL1 gene on …
recombination between the BCR gene on chromosome 22 and the ABL1 gene on …